Gliomas -- a highly aggressive form of brain cancer that strikes approximately 10,000 Americans annually -- tragically claim the lives of 75 percent of its victims within two years and virtually all within five years. But what if there was an alternative treatment for gliomas that could selectively target the cancer while leaving healthy cells intact ? And what if federal bureaucrats were aware of this treatment, but deliberately withheld this information from the public ? Sadly, the questions posed above are not entirely hypothetical. Let me explain. In Emerging Clinical Applications for Cannabis and Cannabinoids: A Review of the Scientific Literature. (NORML Foundation, 2008) One chapter in this book, which summarized the findings of more than 30 separate trials and literature reviews, was dedicated to the use of cannabinoids as potential anti-cancer agents, particularly in the treatment of gliomas. You might not be familiar with this scientific research? BUT Your government IS . The first experiments in the USA , documenting cannabis s potent anti-cancer effects took place in 1974 at the Medical College of Virginia at the behest federal bureaucrats. The results of that study, reported in an Aug. 18, 1974, Washington Post newspaper feature, were that marijuana's primary psychoactive component, THC, "slowed the growth of lung cancers, breast cancers and a virus-induced leukemia in laboratory mice, and prolonged their lives by as much as 36 percent." That possible advancements in the treatment of cancer may have been achieved over the past 34 years had U.S. government officials chosen to advance -- rather than suppress -- clinical research into the anti-cancer effects of cannabis? I would speculate that its all to do with money and there love of it .
No comments:
Post a Comment